Virtual and in-person events are planned for Washington, DC, and Minneapolis, MN, during the trade group gathering.
The ongoing coronavirus pandemic, medical device user-fee negotiations, reimbursement for innovative technology and a global shortage of semiconductors are among the key issues trade organization AdvaMed plans to spotlight at its annual conference next week, group leaders said at a 23 September press conference.
The meeting will take place from 27-30 September under a hybrid model, with events being held virtually as well as on the ground in Washington, DC, and Minneapolis, MN....
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.
Mirvie launched Encompass, a blood test to help identify women over age 35 who are at moderate risk for preeclampsia, and will conduct additional studies to support reimbursements from payers.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.
The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.
Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.
